Caliber Imaging & Diagnostics Inc. Stock Analysis LCDX

Caliber Imaging & Diagnostics, Inc. operates as a medical technologies company that designs, develops, and markets imaging solutions that shows tissue at the cellular level. The company is headquartered in Andover, Massachusetts and currently employs 28 full-time employees. The company went IPO on 2012-02-27. The firm designs, develops, and markets imaging solutions that show tissues at the cellular level. The company offers in-vivo confocal microscopes designed specifically for imaging skin and other tissue. Its Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye. The company has developed the VivaScope, a robust suite of imaging products. Its telepathology system allows near real-time collaboration with remote specialists. Its clinical products include VivaScope 1500, Vivascope System, Vivascope 2500, Vivanet & Vivascan, and VivaScope 3000. Its research products include RS-G4 Upright, RS-G4 Inverted, Specialty Confocal Microscopes and Research Software Suite. The VivaScope 1500 reflectance confocal imaging system offers a non-invasive way to image the skin in vivo from the surface to the superficial collagen layers.